Brent Saunders, Bausch + Lomb CEO (Richard Drew/AP Images)
Bausch + Lomb and Novaliq win approval for dry eye disease treatment
Bausch + Lomb and Novaliq secured an approval for their dry eye disease drop on Thursday, to be marketed as Miebo.
The drug, also known as …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
